Cargando…
Intra-Accumbens Injection of a Dopamine Aptamer Abates MK-801-Induced Cognitive Dysfunction in a Model of Schizophrenia
Systemic administration of the noncompetitive NMDA-receptor antagonist, MK-801, has been proposed to model cognitive deficits similar to those seen in patients with schizophrenia. The present work investigated the ability of a dopamine-binding DNA aptamer to regulate these MK-801-induced cognitive d...
Autores principales: | Holahan, Matthew R., Madularu, Dan, McConnell, Erin M., Walsh, Ryan, DeRosa, Maria C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135623/ https://www.ncbi.nlm.nih.gov/pubmed/21779401 http://dx.doi.org/10.1371/journal.pone.0022239 |
Ejemplares similares
-
Antidepressant Effects of (+)-MK-801 and (-)-MK-801 in the Social Defeat Stress Model
por: Yang, Bangkun, et al.
Publicado: (2016) -
Buspirone Counteracts MK-801-Induced Schizophrenia-Like Phenotypes through Dopamine D(3) Receptor Blockade
por: Torrisi, Sebastiano Alfio, et al.
Publicado: (2017) -
The effects and mechanism of environmental enrichment on MK-801 induced cognitive impairment in rodents with schizophrenia
por: Xu, Jinwei, et al.
Publicado: (2022) -
Quetiapine Attenuates Schizophrenia-Like Behaviors and Demyelination in a MK-801–Induced Mouse Model of Schizophrenia
por: He, Jue, et al.
Publicado: (2020) -
The Influence of the CB1 Receptor Ligands on the Schizophrenia-Like Effects in Mice Induced by MK-801
por: Kruk-Slomka, Marta, et al.
Publicado: (2016)